Hook & thesis
Newmark (NMRK) is an actionable long right now. The stock is trading near $15.03, sits well below its 52-week high of $19.84, and is priced at roughly a 17.9x P/E with an EV/EBITDA of 6.44 and EV/Sales of 1.27. Those multiples are modest for a commercial real estate services firm that has demonstrated high single-digit to double-digit revenue growth and is actively adding capabilities via acquisitions.
My trade thesis: buy NMRK ahead of Q2 earnings and near-term catalysts because the market is underrating the company’s revenue momentum, underappreciating the strategic value of the Altus Canadian appraisals deal, and failing to price in a returning transaction cycle. This is a mid-term tactical trade designed to capture upside through the earnings cadence and integration progress while keeping downside disciplined with a tight stop.
What Newmark does and why it matters
Newmark provides commercial real estate services to tenants, investors, owners, developers and corporates. Its business lines include leasing, capital markets and investment sales, valuation and advisory, project and development management, and property/facility management. The company operates globally from approximately 170 offices and employs roughly 8,800 professionals—scale that drives cross-selling and higher-margin advisory work.
Why the market should care: Newmark is positioned to benefit from a gradual recovery in transaction volumes, higher origination and advisory activity, and continued outsourcing of real estate operations. The company’s recent acquisition of Altus Group’s Canadian appraisals business (expected to close on 03/01/2026) strengthens Newmark’s valuation and advisory capabilities in Canada and gives it multiyear access to ARGUS Intelligence data—an operationally accretive bolt-on that should help both top-line growth and margin expansion over time.
Fundamentals and numbers that matter
Key metrics:
| Metric | Value |
|---|---|
| Current price | $15.03 |
| Market cap | $2.67B |
| Enterprise value | $4.41B |
| P/E | ~17.9x |
| EV/EBITDA | 6.44x |
| Price/Sales | 0.77x |
| Dividend yield | ~1.0% |
| Free cash flow (most recent) | -$734,991,000 |
| Debt/equity | 1.4 |
Recent revenue context: Newmark reported >$3.1B in revenue for Q3 2025 and nearly $2.8B for full-year 2024, indicating a sizable, transaction-driven top line. Newsflow earlier in 2026 highlights a ~20% revenue growth profile cited by analysts when comparing Newmark to larger peers, reinforcing the view that the company is growing faster than the broader service market.
Technicals and market interest: Average daily volume is roughly 1.17M and short interest rose to ~6.4M shares as of 06/15/2026 (about 4.8 days to cover). Momentum indicators are constructive—10-day and 20-day SMAs sit just under current price, 50-day SMA modestly higher, RSI neutral at ~51, and MACD showing bullish momentum on the histogram. That technical bias supports a measured long into earnings rather than a speculative punt.
Valuation framing
At a market cap of $2.67B and EV of $4.41B, Newmark’s EV/EBITDA of 6.44x and P/E of ~17.9x look reasonable given the company’s growth trajectory and the recent strategic acquisition. Price/Sales of 0.77x suggests the market is valuing Newmark more like a low-growth services company than a recovering, higher-turnover advisory platform. If transaction volumes and advisory fees re-accelerate, multiples should re-rate toward a higher EV/EBITDA and P/E multiple—making the current price a tactical entry point.
It’s worth noting free cash flow was negative in the recent period (-$734.99M), which places a premium on operational execution and the pace of integration for acquisitions. The valuation is attractive only if management can convert revenue growth into improved margins and positive cash generation over the next several quarters.
Catalysts (2-5)
- Q2 earnings report: an earnings beat or conservative guidance upside could re-rate the stock quickly.
- Integration of Altus’ Canadian appraisals business (expected close 03/01/2026) - early signs of cross-selling or incremental high-margin work would validate the deal rationale.
- Sector tailwinds: a continuing CRE recovery that drives higher transaction and origination volumes across leasing and capital markets.
- Potential dividend stability or modest buyback announcement that signals capital allocation discipline.
Trade plan - exact actionable setup
Trade direction: long.
Entry price: $15.03.
Stop loss: $13.50.
Target price: $17.50.
Horizon: mid term (45 trading days). The rationale for the 45-day window is that it spans the Q2 earnings release and allows time for the market to digest results and any incremental color on the Altus integration and transaction volumes. If the stock follows through on a positive print and higher guidance, the position can be held past 45 days; if the print is neutral or negative, the stop at $13.50 protects downside.
Position sizing: treat this as a tactical allocation given the company’s leverage and recent negative free cash flow—limit to a small percentage of risk-capital and adjust depending on conviction after earnings.
Risks and counterarguments
- Leverage and cash generation risk: Debt/equity is ~1.4 and recent free cash flow was deeply negative (-$734.99M). If revenue growth fails to convert into cash, the balance sheet could constrain capital allocation and increase refinancing risk.
- Transaction sensitivity: A large portion of Newmark’s revenue is transaction-based. A renewed slowdown in commercial real estate transactions or tighter financing conditions would directly pressure revenues and earnings.
- Integration risk: The Altus Canadian appraisals acquisition is strategically positive, but execution risk exists. If cost synergies or cross-selling take longer than expected, margin improvement may be delayed.
- Competition and fee compression: Large incumbents and global brokerages (who compete aggressively on large mandates) could pressure pricing and market share, limiting margin expansion.
- Volatility from short interest: Short interest has been elevated, which can amplify downside moves on bad prints and increase volatility into earnings.
Counterargument: The primary pushback is the free cash flow hole and leverage. Critics will say that until Newmark meaningfully generates positive operating cash, valuation metrics mean less—earnings quality and balance sheet strength matter. That is fair. This trade accepts that risk but prices it by using a disciplined stop and a mid-term horizon that allows time for operational improvement to show up in the numbers.
What would change my mind
- Confirming negative: if Q2 results show materially weaker transaction volume, further cash burn, or management withdraws prior growth guidance, I would exit immediately and reassess—this would invalidate the thesis.
- Confirming positive: if management reports a clear path to positive free cash flow, accelerated margin improvement, or tangible ARR-like revenue from valuation and advisory contracts post-Altus close, I would increase the position and extend the holding to a long-term horizon.
Conclusion
Newmark presents a concrete, actionable trade into Q2 earnings. The combination of reasonable valuation (P/E ~18x, EV/EBITDA 6.44x), a strategic tuck-in that boosts advisory capabilities, and constructive technicals makes this a tactical long with defined risk controls. The trade is not without real balance sheet and cash-flow risks, so keep position size measured and use the $13.50 stop to protect against a downside earnings surprise. If management can show the market a credible cash-flow improvement path and execution on the Altus integration, this setup should offer upside to $17.50 in the mid-term and potentially beyond.
Key dates
- Altus appraisals transaction expected close: 03/01/2026.
- Dividend-related dates (recent cycle): record date 05/14/2026, payable date 05/29/2026.
Trade idea summary: Long NMRK at $15.03, stop $13.50, target $17.50, horizon mid term (45 trading days). Keep size disciplined; watch earnings and integration updates closely.